Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03633331 |
|---|---|
| Brief Title: | Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
| First Submitted : | August 7, 2018 |
| First Submitted that Met QC Criteria : | August 15, 2018 |
| First Posted : | August 16, 2018 |
| Results First Submitted : | September 17, 2021 |
| Results First Submitted that Met QC Criteria : | September 17, 2021 |
| Results First Posted : | October 15, 2021 |
| Last Update Submitted that Met QC Criteria : | September 17, 2021 |
| Last Update Posted : | October 15, 2021 |